Expression of mutant nuclea β-catenin correlates with non-invasive hepatolocellular carcinoma, absence of portal vein spread, and good prognosis

Journal of Pathology

Volumn 193, Issue 1, 2001, Pages 95-101

  Mao, Tsui Lien ^a   Chu, Jan Show ^a   Jeng, Yung Ming ^a   Lai, Po Lin ^a   Hsu, Hey Chi ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Catenin; Hepatocellular carcinoma; Immunohistochemistry; Mutation; Prognosis; Tumour invasion

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; HEPATITIS B SURFACE ANTIGEN; MUTANT PROTEIN; NUCLEAR PROTEIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL MEMBRANE; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; EMBRYO AXIS; EMBRYO PATTERN FORMATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR THROMBUS; VIRUS CARRIER; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CHILD; CYTOSKELETAL PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PORTAL VEIN; PROGNOSIS; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034746832     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3     Document Type: Article

References (37)

1. Tumor invasiveness and prognosis in resected hepatocellular carinoma: Clinical and pathogenetic implications
2. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: Association with tumor growth and invasiveness
3. Mutations of p53 gene in hepatocellular carcinoma (HCC) correlate with tumor progression and patient prognosis: A study of 138 patients with unifocal HCC
4. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC
5. -/- colon carcinoma
6. Stabilization of β-catenin by genetic defects in melanoma cell lines
7. Cadherin catenin complex: Protein interactions and their implications for cadherin function
8. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex
9. Expression of the E-cadherin catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases
10. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation
11. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma
12. Association of the APC gene product with β-catenin
13. Embryonic axis induction by the armadillo repeat domain of β-catenin: Evidence for intracellular signalling
14. Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo
15. Functional interaction of β-catenin with the transcription factor LEF-1
16. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
17. β-catenin expression in human cancers
18. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
19. Reduced expression of the cadherin catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
20. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
21. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
22. Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas
23. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma
24. Genomic organization of the human β-catenin gene (CTNNBI)
25. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
26. Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma
27. Expression of β-catenin in normal breast tissue and breast carcinoma: A comparative study with epithelial cadherin and α-catenin
28. Patterns of α- and β-catenin and E-cadherin expression in colorectal adenomas and carcinomas
29. Expression of E-cadherin-associated molecules (α-, β-, γ-catenins and p120) in colorectal polyps
30. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
31. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas
32. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
33. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3
34. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
35. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
36. Beta-catenin mutation in carcinoma of the uterine endometrium
37. β-catenin expression pattern in stage I and II ovarian carcinomas: Relationship with β-catenin gene mutations, clinico-pathological features, and clinical outcome